Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvancedadvt Regulatory News (ADVT)

Share Price Information for Advancedadvt (ADVT)

Share Price is delayed by 15 minutes
Get Live Data
155.00    0.00 (0.00%)
Bid:
150.00
Ask:
160.00
Spread: 10.00 (6.667%)
Market Cap: £205.95m
ADVT Live PriceLast checked at - London Stock Exchange

Intraday Advancedadvt Share Chart

Investor Presentation

15 Nov 2024 08:30

RNS Number : 4206M
AdvancedAdvT Limited
15 November 2024
 

15 November 2024

 

AdvancedAdvT Limited

 

Investor Presentation

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", "the Group"), the international software solutions provider for the business, compliance, and resource management, is pleased to announce that Vin Murria and Gavin Hugill will provide a live presentation relating to the Investor Presentation via Investor Meet Company on 19 Nov 2024, 10:30 GMT.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 18 Nov 2024, 09:00 GMT, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet AdvancedAdvT Limited via:

 

https://www.investormeetcompany.com/advancedadvt-limited/register-investor

 

Investors who already follow AdvancedAdvT Limited on the Investor Meet Company platform will automatically be invited.

 

 

Enquiries:

 

AdvancedAdvT Limited

Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer

c/o Meare Consulting

Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

Philip Davies / Sam Butcher

KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 

 

Meare Consulting 

Adrian Duffield

Tel: 07990 858548

 

Note to Editors

 

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

 

The Group's operations are IBSS (financial management software), CHKS (AI based healthcare intelligence compliance and accreditation software), Retain (global resource planning and talent management software), WFM (workforce management software provider) and Celaton, a machine-learning AI based intelligent process automation ("IPA") platform (inSTREAM).

 

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUVAWRSUUAARA
Date   Source Headline
4th Mar 20267:00 amRNSShare Buyback Programme and Return of Capital
25th Feb 20267:00 amRNSFull year trading ahead of market expectations
6th Feb 20264:36 pmRNSHolding(s) in Company
6th Jan 20267:00 amRNS-RAcquisition of MatchingCore IP
4th Dec 20257:00 amRNSExercise of Warrants
4th Nov 20257:00 amRNSInterim Results for Six Months to 31 August 2025
29th Oct 20257:00 amRNSNotice of Half Year Results
2nd Oct 20257:00 amRNSHalf Year Trading Update
20th Aug 20252:18 pmRNSHolding(s) in Company
15th Aug 20252:50 pmRNSHolding(s) in Company
5th Aug 202512:06 pmRNSResult of AGM
18th Jul 20254:00 pmRNSNotice of AGM
1st Jul 20252:09 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSFinal Results for Year Ending 28 February 2025
3rd Jun 20251:20 pmRNSHolding(s) in Company
3rd Jun 202512:03 pmRNSHolding(s) in Company
30th May 20257:00 amRNSAcquisition of Goss Technology Limited
14th May 20257:00 amRNSAcquisition of HFX Limited
27th Feb 20253:30 pmRNSBoard Change
20th Feb 20254:00 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSTrading Update
21st Jan 20254:02 pmRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
24th Dec 20248:17 amRNSHolding(s) in Company
15th Nov 20248:30 amRNSInvestor Presentation
14th Nov 20247:00 amRNSInterim Results for 6 months to 31 August 2024
8th Nov 20247:00 amRNSNotice of Half Year Results
3rd Oct 20249:45 amRNSHolding(s) in Company
27th Sep 20247:00 amRNSHalf Year Trading Update
20th Aug 20243:05 pmRNSResult of AGM
6th Aug 20244:49 pmRNSNotice of AGM
30th Jul 202411:00 amRNSDirector/PDMR Shareholding
22nd Jul 20247:00 amRNSAudited Results for 8 Months to 29 February 2024
19th Jul 20241:02 pmRNSNotice of Final Results
1st Jul 20247:45 amRNSCompletion of Acquisition of Celaton
24th May 202411:15 amRNSDirector/PDMR Shareholding
8th May 20242:15 pmRNSHolding(s) in Company
7th May 20247:00 amRNSAcquisition and Year-End Trading Update
29th Apr 20244:10 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSHalf-year Report
21st Mar 20247:00 amRNSNotice of Interim Results
29th Jan 20247:00 amRNSCompletion of Disposal of Synaptic Software
16th Jan 20245:45 pmRNSHolding(s) in Company
10th Jan 20248:00 amRNSReadmission - ADVANCEDADVT LIMITED
10th Jan 20247:00 amRNSAdmission to AIM
8th Jan 20247:00 amRNSPublication of Admission Document & Trading Update
22nd Dec 20238:00 amRNSSchedule One - AdvancedAdvT Limited
5th Dec 20237:00 amRNSUpdate on Cancellation of Listing
17th Aug 20232:55 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.